10 biggest corporate deals of 2015
The deal would create the world’s largest drug company, bringing Pfizer’s erectile dysfunction drug Viagra and Allergan’s wrinkle treatment Botox under one company.
Value: $148.6 billion
Announced: November
Status: Pending
(ANDREW GOMBERT / EPA)Associated Press
It has been a record year for corporate deals. Companies made more than $4.7 trillion in deals so far this year, surpassing 2007 as the top year for deals, according to Dealogic. The most recent deal, a tie-up of Dow Chemical and DuPont announced Friday, adds more than $60 billion to the total.
AB InBev, already the world’s largest brewer, will get even bigger after the deal closes. AB InBev makes Budweiser beer, while SABMiller makes Miller Genuine Draft.
Value: $105.6 billion
Announced: October
Status: Pending
(Gene J. Puskar / AP)
Oil and gas company Shell says it wants to buy rival BG Group to boost its presence in the liquefied natural gas market.
Value: $69.8 billion
Announced: April
Status: Pending
(Daniella Beccaria / AP)
Dell, the maker of personal computers, is buying EMC to get into the growing data-storage industry.
Value: $66 billion
Announced: October
Status: Pending
(Steven Senne / AP)The two companies expect to combine and then split into three publicly traded companies focusing on agriculture, material science and specialty products.
Value: $62.4 billion
Announced: December
Status: Pending
(Mark Makela / Getty Images)
Combining the cable companies will create one of the largest TV and Internet providers in the U.S.
Value: $56.8 billion
Announced: May
Status: Pending
(Kevork Djansezian / Getty Images)HJ Heinz buying Kraft Foods created the third-largest food company, bringing together well-known brands Oscar Mayer hot dogs, Ore-Ida frozen french fries and Heinz ketchup.
Value: $53.8 billion
Announced: March
Status: Completed
(Scott Olson / Getty Images)Based on enrollments, Anthem buying Cigna would create the nation’s largest health insurer.
Value: $51.9 billion
Announced: June
Status: Pending
(Matt Rourke / AP)
Pharmaceutical company Teva is in the process of buying Allergan’s generic drug business.
Value: $40.5 billion
Announced: July
Status Pending
(Dan Balilty / AP)